Orange Book product · Brand (NDA)
VEPPANU
VEPDEGESTRANT
At a glance
May 01, 2026
Approved
Brand (NDA)
Application
Not listed
TE code
3
Listed patents
Key dates
Approval
FDA approval date of this drug product.
May 01, 2026
2 mo ago
Today
Exclusivity ends · NCE
New chemical entity exclusivity (5 years)
May 01, 2031
in 4 yr 11 mo
Patent 10899742 expires
Listed method-of-use patent (U-4278) expiration.
Dec 01, 2037
in 11 yr 7 mo
Patent 11597720 expires
Listed drug substance patent expiration.
Dec 01, 2037
in 11 yr 7 mo
Patent 10647698 expires
Listed drug substance patent expiration.
Jan 30, 2038
in 11 yr 9 mo
Pharmaceutical detail
Active ingredient
VEPDEGESTRANT
Strength
100MG
Dosage form
TABLET
Route
ORAL
TE code
Not listed
Application
NDA 219835
Product number
001
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
Marketing exclusivity (1)
- NCENew chemical entity exclusivity (5 years)
May 01, 2031
in 4 yr 11 mo
Listed patents (3)
| Patent | Expires | In | Type |
|---|---|---|---|
| 10899742 | Dec 01, 2037 | in 11 yr 7 mo | U-4278 |
| 11597720 | Dec 01, 2037 | in 11 yr 7 mo | SubstanceProductU-4278 |
| 10647698 | Jan 30, 2038 | in 11 yr 9 mo | SubstanceProduct |
